Revitalizing Sleep for Brain Health: The NMN Solution to Dementia Risk
A recent study led by Matthew P. Pase at Monash University reveals a concerning link between the age-related decline of slow-wave sleep and an increased risk of dementia. The study, published in JAMA Neurology, underscores the critical role of slow-wave sleep in maintaining brain health as we age. Delving into potential interventions for age-related cognitive decline, the spotlight turns to Nicotinamide Mononucleotide (NMN), an anti-aging supplement gaining recognition. NMN, a precursor to NAD+, addresses the decline in cellular function associated with aging. Notably, NMN's unique attribute lies in its potential to enhance sleep quality, a crucial factor highlighted by the study. As the quest for cognitive well-being evolves, NMN emerges as a promising avenue for those seeking proactive measures in the intricate relationship between sleep, aging, and cognitive decline.
更多+